2018
DOI: 10.5588/ijtld.17.0312
|View full text |Cite
|
Sign up to set email alerts
|

Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?

Abstract: Consulting widely regarding which TPP attributes are valued most by users and decision-makers involved in introducing TB diagnostics can assist TB test developers to prioritize their investments, and guide decision making if trade-offs are necessary.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Country stakeholders of 14 countries ranked sensitivity the most important element in the TPPs for TB diagnostics. 33 Yet, a TB test developer argues that in order to optimise accessibility at POC, a developer might have to compromise accuracy (test developer 20). Regulatory approval processes should be cognizant of this trade-off and require evidence accordingly.…”
Section: Research and Developmentmentioning
confidence: 99%
“…Country stakeholders of 14 countries ranked sensitivity the most important element in the TPPs for TB diagnostics. 33 Yet, a TB test developer argues that in order to optimise accessibility at POC, a developer might have to compromise accuracy (test developer 20). Regulatory approval processes should be cognizant of this trade-off and require evidence accordingly.…”
Section: Research and Developmentmentioning
confidence: 99%
“…A high-level guideline [ 16 ] and a roadmap [ 17 ] have been published recently. Adepoyibi et al [ 18 ] conducted a survey among laboratory personnel, national tuberculosis control program managers, donors, technical experts, patients and researchers, and asked them to rank the items in a TPP for tuberculosis diagnostic tools by their perceived importance. Denkinger et al [ 19 ] included patients among stakeholders in the prioritization of TPP items for tuberculosis diagnostic tools.…”
Section: Introductionmentioning
confidence: 99%